Given the importance of IL-33/ST2 axis in protection against metabolic disease, we sought to investigate whether IL-33 was differentially associated with ST2 among individuals with normoglycemia, prediabetes, and T2D. This evidence concerns the gene IL33 and Other metabolic disease.